-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
30-40% of patients with acromegaly will develop colon polyps, leading to an increased risk of colon cancer .
30-40% of patients with acromegaly will develop colon polyps, leading to an increased risk of colon cancer .
This study aimed to evaluate the incidence of colon polyps before and after metformin treatment in patients with acromegaly, and to explore its potential protective effects.
Research Process
Research ProcessThis is an exploratory cross-sectional study conducted at two tertiary referral centers in Italy.
Screening
Polyp histological classification
Polyp histological classificationThe overall prevalence of colon polyps is 36%.
The overall prevalence of colon polyps is 36%.
multi-factor analysis
multi-factor analysisMultivariate analysis showed that colon polyps were significantly negatively correlated with metformin intake (OR 0.
Colon polyps are significantly negatively correlated with metformin intake (OR 0.
Metformin may have a certain protective effect on the occurrence and development of colon polyps in patients with acromegaly.
Original source:
Albertelli M, Nazzari E, Dotto A et al.
org/10.
1530/EJE-20-0795" target="_blank" rel="noopener">Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study in this message